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The paralogues RrpA and RrpB which are members of MarR family of DNA binding proteins 30 
are important for the survival of the global bacterial foodborne pathogen Campylobacter 31 
jejuni under redox stress. We report that RrpA is a positive regulator of mdaB, encoding a 32 
flavin-dependent quinone reductase that contributes to the protection from redox stress 33 
mediated by structurally diverse quinones, whilst RrpB negatively regulates the expression of 34 
cj1555c (renamed nfrA for NADPH-flavin reductase A), encoding a flavin reductase. NfrA 35 
reduces riboflavin at a greater rate than its derivatives, suggesting exogenous free flavins are 36 
the natural substrate. MdaB and NfrA both prefer NADPH as an electron donor. Cysteine 37 
substitution and post-translational modification analyses indicated that RrpA and RrpB 38 
employ a cysteine-based redox switch. Complete genome sequence analyses revealed mdaB 39 
is frequently found in Campylobacter and related Helicobacter spp., whilst nfrA is 40 
predominant in C. jejuni strains. Quinones and flavins are redox cycling agents secreted by a 41 
wide range of cell-types that can form damaging superoxide by one-electron reactions. We 42 
propose a model for stress adaptation where MdaB and NfrA facilitate a two-electron 43 
reduction mechanism to the less toxic hydroquinones, thus aiding survival and persistence of 44 
this major pathogen. 45 
 46 
Importance 47 
Changes in cellular redox potential results in alteration in the oxidation state of intracellular 48 
metabolites and enzymes, consequently, cells make adjustments that favor growth and 49 
survival. The work we present here answers some of the many questions that have remained 50 
elusive over the years of investigation into the enigmatic microaerophile bacterium, 51 
Campylobacter jejuni. We employed molecular approaches to understand the regulation 52 



























































reductases, both serve as major pools of cellular redox-active molecules. This work extends 54 
our knowledge on bacterial redox sensing mechanisms and the significance of hemostasis.  55 
 56 
Introduction 57 
Campylobacter jejuni is a microaerophilic Gram-negative bacterium and is the leading cause 58 
of bacterial foodborne gastroenteritis worldwide (1). The high prevalence of C. jejuni is 59 
accredited to its ability to survive in a variety of niches including the natural environment and 60 
within its avian and mammalian hosts, despite not growing in aerobic environments (2).  61 
 62 
The sensitivity of C. jejuni to both oxygen and oxidative stress is a major defining feature 63 
that has presented a conundrum in terms of the prevalence of the bacterium in the natural 64 
environment and its success as a global enteric pathogen. Genomic data, mutant phenotypes 65 
and biochemical analyses have shown that C. jejuni strains have an extensive complement of 66 
oxidative stress protection systems (3), that allows fine tuning of its adaptation to in vivo and 67 
ex vivo environments. These include the peroxidatic enzyme catalase and the thiol 68 
peroxidases Tpx, Bcp and AhpC as well as superoxide dismutase (4, 5).             69 
 70 
The production of most of the above mentioned oxidative stress protection enzymes are 71 
controlled at the transcriptional level by the regulators PerR, CosR and Fur (3). However, the 72 
re-annotation of the C. jejuni NCTC 11168 genome led to the discovery of two novel redox-73 
sensing MarR-homologue transcriptional regulators that were named RrpA (cj1546) and 74 
RrpB (cj1556) (6, 7). Using C. jejuni 11168H, a hypermotile derivative of the standard strain 75 
NCTC 11168 (8, 9), a link between RrpA and RrpB with oxidative stress was reported based 76 



























































compounds, hydrogen peroxide, menadione and cumene hydroperoxide (6, 7, 10). 78 
Additionally, multilocus sequencing typing (MLST) revealed that rrpA was present in over 79 
99% of 3,746 C. jejuni strains, but the presence of rrpB predominated in livestock-associated 80 
strains (10). This suggests a correlation between possession of both transcriptional regulators 81 
and the ability of C. jejuni to adapt and survive in diverse niches.  82 
 83 
Here, we asked what genes are under the regulatory control of RrpA and RrpB and what their 84 
roles are in C. jejuni redox metabolism. We identified mdaB and nfrA, encoding two novel 85 
reductases that are under the transcriptional control of RrpA and RrpB, respectively, and we 86 
revealed the regulation mechanism of RrpA and RrpB to their DNA substrates. We show 87 
MdaB is a flavin-dependent NADPH-quinone reductase, which has a role in protecting the 88 
cell from quinone stress mediated damage, while NfrA is an NADPH-riboflavin reductase. 89 
Database searches revealed that MdaB is predominant in both Campylobacter spp. and the 90 
related Helicobacter spp., but NfrA is more often found in C. jejuni strains commonly 91 
associated with human infection.  92 
 93 
Quinones are amongst the main chemical compounds produced by plants and 94 
microorganisms and have attracted significant interest because of their antimicrobial 95 
activities (11). Quinones are well known for their active role in the electron transport chain of 96 
most organisms in the form lipid-soluble electron carriers (e.g., ubiquinone and 97 
menaquinones) (12). In contrast, water-soluble quinones are toxic as pro-oxidants or 98 
electrophiles (13-16), and act as catalysts to generate reactive oxygen species (ROS) by 99 
undergoing one‐electron reduction to yield semi‐quinone radical anions that reduce molecular 100 
oxygen. This produces ROS such as the superoxide anion (O2•-) and hydrogen peroxide 101 




























































Flavin mononucleotide (FMN) and flavin dinucleotide (FAD), and rarely riboflavin itself, 104 
form an integral part of the redox active sites of flavoproteins as prosthetic groups (19). The 105 
core of flavin compounds consist of a heterocyclic isoalloxazine ring that exist in three 106 
different redox states: oxidized form, one-electron reduced radical semiquinone and two-107 
electron fully-reduced hydroquinone (20). In fact, this property makes flavin molecules 108 
unique compounds in nature and fit to serve in broad roles as biocatalysts. However, similarly 109 
to quinones, flavo-semiquinones can transfer an electron to oxygen generating the superoxide 110 





 and O2 into H2O2. The simultaneous production of H2O2 and Fe
2+ 
in cells may 112 
promote the production of hydroxyl radical via the Fenton reaction resulting in cell death 113 
(22).  114 
 115 
Given their propensity for highly toxic superoxide production, both quinones and flavins are 116 
effective antimicrobials (23, 24) that C. jejuni may encounter in in vivo and ex vivo 117 
environments. Thus, we propose that possession of the MdaB and NfrA enzymes allows a 118 
safer two-electron reduction to the fully reduced forms of these compounds and could be a 119 
significant adaptation for the persistence and prevalence of this problematic pathogen. 120 
 121 
Results 122 
Disruption of rrpA, rrpB and rrpAB shows altered transcription profiles in C. 123 
jejuni 11168H.  124 
The pleotropic phenotype of the C. jejuni ∆rrpA, ∆rrpB and ∆rrpAB strains (6, 7, 10), led us 125 



























































and ∆rrpAB defined mutants by RNA-Seq. Bacteria were cultured in brucella broth at 37 °C 127 
in microaerobic condition to OD600nm = ~0.45 (mid-log growth phase), five biological 128 
replicates were analyzed. Genes that were significantly differentially regulated between the 129 
wild type and mutant strains are presented in Table 1 (genes that were differentially 130 
expressed >1.5 log
2
 fold change compared to the wild type were considered significant; 131 
p<0.05). 132 
 133 
There was a modest difference in gene expression between the wild type strain and its ∆rrpA 134 
or ∆rrpB mutants; the putative autotransporter gene capA (cj1677), was significantly 135 
upregulated in both the ∆rrpA and ∆rrpB mutants (Table 1). RrpB was previously reported to 136 
be an autoregulator (6), and interestingly, in both ∆rrpB and the ∆rrpAB mutant strains, rrpB 137 
and the gene directly upstream on the reverse strand, cj1555c, were significantly upregulated 138 
(Table 1). cj1555c codes for a hypothetical protein of unknown function, however, a protein 139 
BLAST search (https://blast.ncbi.nlm.nih.gov/) indicated that this gene is an NAD(P)H-140 
flavin reductase, which we have named nfrA, NAD(P)H-flavin reductase A. 141 
 142 
Additionally, in the ∆rrpA mutant, cj1545c (mdaB; modulator of drug activity B) was 143 
downregulated based on individual statistical test (p<0.05), however, when the p-values were 144 
adjusted for multiple comparison, the significance was lost. Nevertheless, this gene was 145 
included in the study (indicated with an asterisk * in Table 1), for two reasons: 1). mdaB was 146 
previously implicated to have a role in oxidative stress defense in C. jejuni and in the closely 147 
related Helicobacter spp. (25, 26); and 2). mdaB is located directly upstream of rrpA on the 148 




























































In the double mutant strain, ∆rrpAB, genes that were significantly upregulated included rrpA; 151 
which was previously also reported to be an autoregulator (7); cj1719c which encodes LeuA 152 
(2-isopropylmalate synthase), an amino acid biosynthesis protein; cj1454c, encoding RimO, a 153 
ribosomal methylthiotransferase that catalyzes the methylthiolation of aspartic acid residue of 154 
ribosomal protein S12; cj1710c, encoding Rnj, involved in the maturation and/or decay of 155 
mRNA; and cj1711c, encoding RsmA, which plays a role in the biogenesis of ribosomes and 156 
has been shown to protect DNA against oxidative stress in some bacteria (27, 28). Two genes 157 
were significantly downregulated, cj0724; which is an uncharacterized molybdenum cofactor 158 
biosynthesis protein and cj0265c; the TorB cytochrome c-type heme-binding subunit of the 159 
TorAB, TMAO/DMSO reductase (Table 1). Tables of all genes are presented in Table. S1a, 160 
Table. S1b and Table. S1c. 161 
 162 
RNA independent from the RNA-Seq was isolated and real-time RT-qPCR was performed 163 
(Fig. 1). RT-qPCR indicated a significant ∼2-fold decrease in the expression of mdaB in both 164 
∆rrpA and ∆rrpAB mutant strains, whilst in the ∆rrpB mutant strain, mdaB was significantly 165 
upregulated by ∼1.5-fold (Fig.1a). In both ∆rrpB and ∆rrpAB mutant strains, nfrA was 166 
significantly upregulated by ∼7-fold (Fig.1b). Expression of capA and rsmA were also 167 
confirmed in all the strains, and their expressions were in line with our RNA-Seq data (Fig. 168 
1c and 1d). 169 
 170 
Our RNA-Seq and RT-qPCR results showed the genes located upstream of rrpA and rrpB, 171 
respectively, were differentially regulated in the mutant strains. Therefore, we speculated that 172 
these genes are under the control of RrpA and RrpB. DNAse I footprinting using dye primer 173 



























































of recombinant RrpAhis6 and RrpBhis6 proteins with the regions upstream of the genes mdaB 175 
and nfrA. 176 
 177 
RrpA and RrpB protect regions with inverted repeat sequences.  178 
 179 
DNAse 1 footprinting was performed as described previously (29), a 500 ng fluorescently 180 
labelled DNA fragment was incubated with various concentrations of recombinant RrpAhis6 181 
and RrpBhis6 ranging from 20 µg to 0 µg at room temperature, as described in the Methods.  182 
The pattern of protection was observed by decreased fluorescent intensity of the 183 
electropherogram (indicated within the dotted lines) (Fig. 2). We also noted non-specific 184 
protection patterns at the highest protein concentrations in all of the samples, possibly due to 185 
promiscuity at high protein concentrations due to low binding affinity. 186 
 187 
We observed protection by purified RrpAhis6 upstream of mdaB and  upstream of the rrpA 188 
translational start sites (Fig. 2a and Fig. 2b), respectively. Purified RrpBhis6 showed 189 
protection upstream of the rrpB translational start site (Fig. 2c). In these protected regions 190 
(highlighted in grey), we identified inverted repeats (IRs) motif (underlined in bold) protected 191 
by RrpAhis6 formed by 6 nt (5′-TATCAT-3′), which are separated by 19 nt for mdaB (Fig. 2d) 192 
and 24 nt for rrpA (Fig 2e), we also identified an IR sequence protected by RrpBhis6 formed 193 
of 6 nt (5’-TTATAA-3’) separated by 17 nt (Fig. 2f). We did not observe protection by 194 
RrpBhis6 upstream of nfrA, possibly due to oxidation of the protein during sample preparation. 195 
However, nucleotide alignment of the region preceding the translation start site of nfrA 196 
identified IR sequence that matched those found within the protected region by RrpBhis6, 197 




























































Oligonucleotides spanning the protected regions were synthesized and Electrophoretic 200 
Mobility Shifts Assays (EMSA) were conducted. A DNA substrate, 50 nM , was co-201 
incubated with final concentration of 0.05 μg of RrpAhis6 and RrpBhis6 proteins in a 20 µl 202 
reaction; formation of protein-DNA complexes were observed in all the EMSAs conducted 203 
(Fig. 3a-d) Specificity of binding was also tested, we found that both RrpAhis6 and RrpBhis6 204 
proteins are able to bind to DNA sequences with mutation to one of the binding sequences 205 
but were unable to bind to DNA that lack both binding sequences (Fig. S1a and Fig. S1b). 206 
This is indicative that RrpA and RrpB recognize regions on the DNA with IR sequences, 207 
which is characteristic of the MarR family transcriptional regulators (30).  208 
 209 
mdaB-rrpA and nfrA-rrpB gene expression respond to a range of exogenous 210 
quinones and flavins, respectively. 211 
 212 
We performed a literature search to identify broad range of quinones that have previously 213 
been shown to have an effect on mdaB analogs (25, 31). We selected the following 214 
compounds due to their structural diversity; Coenzyme Q1 (Ubiquinone), Pyrroloquinoline 215 
quinone (Methoxatin), Sodium anthraquinone-2-sulfonate, 1,2-Naphthoquinone (Ortho-216 
naphthoquinone), 1,4-napthoquinone, p-Benzoquinone, 2,3-dichloro-1,4-napthoquinone 217 
(Dichlone), 2,3,5,6-tetrachloro-1,4-benzoquinone (Chloranil), 2,6-dichloroquinone-4-218 
chloromide (Gibb’s reagent), 2-hydroxy-1,4-naphthoquinone (Lawsone), 5-hydroxy-1,4-219 
Naphthoquinone (Juglone), 5-hydroxy--2-methyl-1,4-Naphthoquinone (Plumbagin). We also 220 
tested gene expression of nfrA and rrpB in response to riboflavin and its derivatives, flavin 221 
mononucleotide (FMN) and flavin dinucleotide (FAD). Growing cultures of C. jejuni 11168h 222 



























































expression at 15 mins and 40 mins was determined by RT-qPCR relative to the control after 224 
normalization using gyrA (Fig. 4).  225 
 226 
In the wild-type strain the expression of mdaB and rrpA were greatly influenced by treatment 227 
with quinone compounds. The greatest effect was observed after treatment with 2-hydroxy-228 
1,4-naphthoquinone; mdaB expression was increased by ~9.6-fold and rrpA by ~3.0-fold 229 
after 15 mins (Fig. 4a) and mdaB expression remained significantly high (~5-fold) after 40 230 
mins post treatment (Fig. S2a). Interestingly, the expression of mdaB was significantly 231 
reduced (~3.0-fold) in the ∆rrpA mutant strain at 15 mins (Fig. 4b) and 40 mins (Fig. S2b). 232 
Similarly, treatment of C. jejuni 11168H with exogenous flavins showed nfrA gene 233 
expression was significantly increased up to ~12-fold after 15 mins of treatment, whilst rrpB 234 
expression was significantly reduced (~2-fold) (Fig. 4c). nfrA expression remained 235 
significantly high after 40 mins post-treatment with riboflavin and FMN (Fig. S2c). These 236 
results also suggest that mdaB and nfrA are under the regulatory control of RrpA and RrpB, 237 
respectively. 238 
 239 
Given that 2-hydroxy-1,4-naphthoquinone and riboflavin had an effect on mdaB-rrpA and 240 
nfrA-rrpB expressions, respectively, we tested their effects on C. jejuni growing cultures; 241 
Optical density (OD600nm) was monitored for 135 mins after the addition of 100 µM 2-242 
hydroxy-1,4-naphthoquinone (Fig. 4d) and 500 µM of riboflavin (Fig. 4e). Addition of 2-243 
hydroxy-1,4-naphthoquinone led to a temporary bacteriostatic effect and reduction in 244 
maximum optical density of strain ΔrrpA, ΔrrpAB and ΔmdaB compared to wild type (Fig. 245 
4d), the addition of riboflavin had a modest effect on the wild type strain but the largest effect 246 
was observed on ΔnfrA mutant strain. As OD can be affected by cell morphology, we also 247 



























































with 2-hydroxy-1,4-naphthoquinone (Fig. 4f) or riboflavin (Fig. 4g). These results were in 249 
line with the optical density measurements. We did not observe any effect on the nfrA mutant 250 
strain at a lower concentration (100 µM) of riboflavin. 251 
 252 
MdaB and NfrA reduce quinones and flavins, respectively.  253 
 254 
We conducted a conserved-domain search on the C. jejuni MdaB and NfrA proteins, MdaB 255 
contains a flavodoxin-like fold (Cl00438), whilst NfrA is a member of a large family that 256 
share a Rossmann-fold NAD(P)H/NAD(P)(+) binding (NADB) domain (Cl21454). MdaB 257 
and NfrA were predicted to be a putative NAD(P)H-quinone reductase and NAD(P)H-flavin 258 
reductase, respectively; we therefore tested the reductase activity of purified recombinant C. 259 
jejuni MdaB and NfrA in the presence of quinones and flavins (riboflavin, FMN and FAD), 260 
respectively. Purified MdaBhis6 showed a flavin absorption spectrum with peaks at 454 nm 261 
and 379 nm, characteristic of a FAD/FMN cofactor protein (Fig. 5a). The isoalloxazine ring 262 
system within flavins generates a yellow color that is also responsible for light absorption in 263 
the UV and visible spectral range such as that observed for MdaBhis6 (25, 32, 33). The 264 
reductase activity of MdaB was determined by monitoring the oxidation of NADPH in the 265 





 protein (Fig. 5b and Fig. 5c). Note that due to interference of substrates at 267 
340 nm, 360 nm was used in these assays and the extinction coefficient for NADPH at 360 268 




. We also found that MdaB had NADPH oxidase 269 
activity under atmospheric oxygen conditions, therefore all assays were performed 270 
anaerobically (Fig. S3a). Some of the quinones tested were incompatible with the assay, due 271 
to insolubility in aqueous buffer (Fig. S3b), scans of all the quinone compounds tested (Fig. 272 




























































The flavin reductase activity of NfrA was determined by measuring the oxidation of 275 
NAD(P)H in the presence of the flavin substrates riboflavin, FMN and FAD. The specific 276 




 protein with 277 
NADPH and NADH as electron donor, respectively. This was indicative of NfrA preference 278 
for NADPH over NADH (Fig. 5d). NfrA dependent reduction of FMN and FAD with 279 





4.8-fold lower than riboflavin) but no significant activity with FAD (Fig. 5e and Fig. S3e). 281 
Riboflavin reduction by NrfA in the presence of NADPH was monitored directly by 282 
performing the assay anaerobically and following the absorbance maximum of riboflavin 283 




 protein was calculated from the 284 




 (Fig. 5f). No 285 




 (Fig. S3f). Spectra scans performed pre- 286 
and post- assay to confirm quantitative reduction of riboflavin are presented in supplementary 287 
file S1 (Fig. S3g). 288 
 289 
RrpAhis6 and RrpBhis6 are post-translationally modified in vitro by treatment with 290 
redox cycling agents  291 
 292 
MarR-like transcription regulators utilize a redox sensing cysteine (Cys) residue “redox-293 
switch” for their activity. We hypothesized that the same mechanism is employed by RrpA 294 
and RrpB. Protein sequence analysis revealed that RrpA has four Cys residues (Cys8, Cys13, 295 




























































We tested the effects of redox cycling compounds on recombinant RrpAhis6 and RrpBhis6 298 
binding to their DNA substrates by EMSA (Fig. 6). Treatment of RrpAhis6 with 10 µM of 2-299 
hydroxy-1,4-naphthoquinone or 50 µM H2O2 did not affect its ability to form a complex with 300 
its DNA substrates; mdaB (Fig. 6a) and rrpA (Fig. 6b).  Our RNA-Seq and RT-qPCR results 301 
indicated that RrpB is a negative regulator of nfrA and rrpB, considering that the environment 302 
within the cell is maintained in a reduced state, EMSAs were performed in the presence of a 303 
reducing agent (dithiothreitol (DTT)) to mimic this condition in vitro. Interestingly, RrpBhis6 304 
formed a higher complex (super-shift) with its substrates in the presence of DTT (Fig. 6c and 305 
6d) and the addition of 25 µM of H2O2 attenuated this protein–DNA complex (Fig. 6c and 306 
6d). This suggested that the de-repression mechanism of RrpB is mediated by redox 307 
compounds. 308 
 309 
We investigated whether RrpA and RrpB Cys residues are modified after treatment with 310 
redox compounds, in vitro. Recombinant proteins were incubated with 50 µM of 2-hydroxy-311 
1,4-napthoquinone or H2O2 on RrpAhis6 and H2O2 on RrpBhis6 at room temperature for 30 312 
mins and the proteins were analyzed by liquid chromatography mass spectrometry (LC-313 
MS/MS). Total ion current (TIC) of the peptides was used to compare the treated samples to 314 
the untreated samples (Table. 2). 315 
 316 
Analysis of RrpAhis6 treated with 2-hydroxy-1,4-napthoquinone or H2O2 showed a peptide 317 
with a mass peak of 2460.1 Da and an m/z of 821.03
3+
, an assigned loss of 34 Da was 318 
detected on Cys8, corresponding to a dehydroalanine (Dha) modification and the second 319 
modification was assigned with the addition of 32 Da, a di-oxidation (Sulfinic acid (Cys-320 
SO2H)) of Cys 13. A doubly-charged peptide with a mass peak of 1110.6 Da and an m/z of 321 
556.30
2+



























































peptide contained a single Cys residue with a matched loss of 34 Da, confirmed as a Dha 323 
modification on Cys33. RrpAhis6 treated with H2O2 showed a peptide with a mass peak of 324 
1126.6 Da and an m/z of 564.30
2+
, which was confirmed as a Dha modification on Cys33 and 325 
a single oxidation on Met28. Dha is a desulphurization event with the potential to destabilize 326 
protein three-dimensional structure by disruption of disulfide bond formation (34). Sulfinic 327 
acid (Cys-SO2H) is stable and forms disulfide bonds with nearby Cys thiol groups, mediated 328 
by ROS and oxidants, both Dha and sulfinic acid modifications are reversible (35). Cys113 in 329 
RrpAhis6 was not matched as the tryptic peptide contained only three residues and was below 330 
the lower mass-to-charge fragmentation window set in the MS method. 331 
 332 
Analysis of RrpBhis6 treated with H2O2 identified a peptide with a mass peak of 1978.95 Da 333 
and an m/z of 990.48
2+
. This was identified as an addition of 64 Da and confirmed as an 334 
irreversible (35) sulfur dioxide modification (Thiosulfonic acid (Cys-SO2-SH)) at Cys8. 335 
Thiosulfonic acid results from over-oxidation of Cys and is a unique byproduct of degraded 336 
Cys-S-SO2-Cys. Degradation of this disulfide bond also produces a Dha modified cysteine 337 
(Fig. S4).  338 
 339 
Modifications to peptides in the untreated samples were also detected, possibly generated 340 
upon sample preparation. PTM peptides with a lower TIC relative to the control were also 341 
detected in the treated samples, as well as possible undesired non-functional amino acids. A 342 
full identification table and peptide intensity values are presented in Table. S2. 343 
 344 
Sequence alignment (36) to other MarR family transcription regulators revealed conserved 345 
Cys residues in RrpA, Cys13, and RrpB, Cys8 (Fig. 7a). To explore the role of Cys residues 346 



























































RrpACys13Ser, RrpACys33Ser, RrpACys113Ser and RrpBCys8Ser. Non-reducing SDS-PAGE was used 348 
to analyze migration of RrpAhis6, RrpBhis6 and their variants. RrpAhis6 and its variants with the 349 
exception of RrpACys13Ser migrated at the size of RrpA dimer (Fig. 7b). RrpBhis6 reduced (0.5 350 
μM DTT) also migrated at the size of RrpB dimer, however, RrpBhis6 oxidized (50 μM H2O2) 351 
and RrpBCys8Ser both migrated at the size of a monomer (Fig. 7b). These results indicate that 352 
the conserved Cys residues in both proteins are critical for the dimeric forms. 353 
 354 
The ability of RrpAhis6 and RrpBhis6 variants to bind DNA substrates was tested by EMSA. 355 
All RrpA variants were able to form protein-DNA complexes (Fig. 7c), with the exception of 356 
the non-conserved RrpACys8Ser. Similarly, RrpB mutation to the conserved sole Cys residue 357 
Cys8 resulted in the inability of RrpBCys8ser to form protein-DNA complexes (Fig. 7d).  358 
 359 
Discussion 360 
We have unraveled the roles of two novel reductases, MdaB (modulator of drug activity B) 361 
and NfrA (Cj1555c), that contribute to the survival and persistence of C. jejuni. mdaB and 362 
nfrA are under the control of RrpA and RrpB, respectively, which are members of the MarR 363 
family of DNA binding proteins. RrpA is highly conserved among C. jejuni strains, whilst 364 
RrpB is predominant in the livestock-associated MLST clonal complex (10, 37), and are 365 
prevalent in strains isolated from humans. In other organisms including Helicobacter spp., 366 
MdaB is a flavin-dependent NADPH-quinone reductase that has been suggested to fully 367 
reduce quinones and subsequently prevents the generation of the highly reactive 368 
semiquinones (38-40). NfrA is a NADPH-flavin reductase, and in other bacteria,  flavin 369 
reductases have been shown to have a role in iron bioavailability and maintain a supply of 370 



























































redox active and the control of nfrA by the redox responsive regulator RrpB, it seems more 372 
likely that NfrA reduces flavins, this potentially prevents generation of toxic semiquinones.  373 
 374 
Organisms with a complex lifestyle such as C. jejuni often possess MarR orthologs or 375 
paralogs, which regulate genes in response to stress, including degradation of harmful 376 
phenolic compounds (2, 30, 42). MarR homologs are usually in genomic loci that are 377 
composed of divergently oriented genes encoding the transcriptional regulator and the 378 
gene(s) under its control (43). Interestingly, mdaB and nfrA are located divergently oriented 379 
upstream rrpA and rrpB, respectively. Analysis of DNA substrate interaction assays showed 380 
RrpA and RrpB bind sequences with inverted repeats (IRs) upstream of the translation start 381 
site of themselves and their target genes on the intergenic regions of the DNA, a common 382 
feature of this regulator family (44, 45). The identified protected regions led us to speculate 383 
that it is likely that the binding sites for RrpA are close enough to the promoter regions of 384 
mdaB and rrpA for the RNA polymerase to initiate transcription, in contrast, RrpB binding 385 
sites are distal from the RNA polymerase binding site, and RrpB repression mechanism is by 386 
destabilizing the DNA open complex (43).  387 
 388 
In C. jejuni, mdaB was reported to have a role in oxidative stress, yet the specific role for its 389 
product has been elusive (3, 46, 47). We present evidence to show that both mdaB and its 390 
regulator RrpA respond to quinones. The redox-active quinone compounds can be 391 
competitively reduced to hydroquinone via a two-electron mechanism by NADPH-quinone 392 
reductases (33, 38, 48). Semiquinone radicals are cytotoxic due to their ability to react with 393 
molecular oxygen and in turn generate superoxide radicals (23). The two-electron transfer 394 
pathway of quinones produces quinols, this two-step pathway minimizes cellular damage due 395 



























































shown to lower the levels of superoxide ions in cell membrane (49). Our results indicate that 397 
C. jejuni MdaB is a quinone reductase with broad substrate specificity, and treatment of C. 398 
jejuni ΔmdaB and ΔrrpA mutants with quinone showed reduction of growth compared to the 399 
parental strain. In both the external environment and in the host and the gut, many organisms 400 
synthesize toxic quinones (50) and derivatives that form core constituents of many 401 
antimicrobial compounds (51-53). It is plausible that C. jejuni would come into contact with 402 
these compounds. We propose that MdaB contributes to the protection of  C. jejuni from 403 
production of semiquinones by competing with the quinone one-electron reduction pathway, 404 
as also suggested by Palyada et al. (26).  405 
 406 
The NADPH-flavin reductase described here is the product of nfrA gene, it belongs to the 407 
family of flavin reductases that were first isolated from luminous marine bacteria (54, 55) and 408 
from human erythrocytes (56). Given that it took a high concentration of riboflavin to have an 409 
effect on growing C. jejuni ΔnfrA mutant strain and NfrA reduces riboflavin at a much higher 410 
rate than its 5' –phosphorylated form (FMN), which is produced by riboflavin kinase within 411 
the cell, is suggestive that unidentified exogenous free flavins are its natural substrates. A 412 
recent study has identified a chemical analogue of riboflavin that has antimicrobial activity. 413 
Roseoflavin (8-demethyl-8-dimethylamino-riboflavin) is a broad-spectrum antibiotic 414 
naturally produced by Streptomyces spp. and has been shown to be effective against several 415 
bacterial species and protozoans (57). Import of this compound was shown to be mediated by 416 
riboflavin transporters and cellular targets for roseoflavin included FMN riboswitches and 417 
flavoproteins (58, 59). Many bacteria employ FMN riboswitches and all cells depend on the 418 
activity of flavoproteins for homeostasis, so inhibition of these systems can be detrimental to 419 
the cell. Similarly to other flavins, roseoflavin has the potential to generate highly toxic 420 



























































two-electron reductant pathway, protecting C. jejuni against reactive flavo-semiquinones and 422 
flavin analogues.  423 
 424 
The distribution of mdaB and nfrA in 374 Campylobacter spp. and 253 Helicobacter spp. 425 
complete genome sequences was studied (Supplementary Table. S3a and Table. S3b). 426 
mdaB was present in all 627 genome sequences analyzed despite the absence of rrpA. nfrA 427 
was absent in Helicobacter spp. sequences analyzed, whilst in the majority Campylobacter 428 
spp., nfrA was predicted as incomplete. In the majority of Campylobacter spp. sequences that 429 
lacked a complete nfrA, rrpB was either absent or partially present. This suggested that mdaB 430 
is important in both organisms. Furthermore, C. jejuni strains that are less frequently isolated 431 
in human infections lack a complete nfrA, this is indicative that these strains have an as yet 432 
unidentified mechanism of flavin reduction.  433 
 434 
RrpA and RrpB share conserved cysteines (Cys) with other MarR family transcription 435 
regulators and in vitro post translational modification analysis indicated these Cys residues 436 
are modified by oxidizing compounds. Our results showed the importance of the conserved 437 
Cys13 in RrpA for dimerization but not for DNA binding. Studies have shown that MarR 438 
transcription regulators form homodimers and their transcriptional regulation ability, but not 439 
DNA binding ability, can depend on the dimeric form (30, 61). We speculate that RrpA 440 
Cys13 is most likely important for transcription regulation. Mutation to the non-conserved 441 
RrpA Cys8, led to its inability to bind DNA substrate possibly due to structure 442 
destabilization. Further work will be needed to investigate the role of Cys 8 in RrpA 443 
structure. Similarly, RrpBCys8Ser was unable to dimerize or form protein-DNA complex with 444 
its substrates, and interestingly treatment with redox cycling compound had the same effects 445 



























































irreversible thiosulfonic acid, we propose that the de-repression mechanism of RrpB is due to 447 
oxidation modification to Cys8. In E. coli, the SoxRS regulatory system detects and is 448 
oxidized by redox cycling compounds such as quinones, and one of the members of the 449 
SoxRS regulon is mdaB (62). From our work, it is now apparent that although C. jejuni has 450 
long been known to lack soxRS genes, the RrpA and RrpB system described here is at least 451 
partly functional analogous. A model for how we believe the regulatory proteins and 452 
protective enzymes allow C. jejuni to combat quinone and flavin mediated oxidative stress is 453 
shown in Fig. 8. 454 
 455 
We also noted other genes were differentially regulated in our regulator mutants, and 456 
although the expression levels were not necessarily related to functional importance, it is 457 
possible that mutations in rrpA and rrpB may affect other pathways that are not investigated 458 
here, in particular, ribosomal genes, autotransporters and amino acid metabolism. However, it 459 
is interesting that expression of leuA was increased in the rrpAB double mutant. The 460 
dehydratase enzymes (LeuCD) of the branched chain amino-acid biosynthesis pathway 461 
contain labile Fe-S clusters and have long been known to be targets for ROS damage in E. 462 
coli (63) and perhaps leuA upregulation reflects this. 463 
 464 
Conclusion 465 
MdaB and NfrA are reductases specific to their substrates and are under the control of the 466 
redox regulators RrpA and RrpB, respectively. MdaB catalyzes the reduction of quinones, 467 
whilst NfrA is a flavin reductase, thus it is possible that both enzymes contribute to C. jejuni 468 
protection against potential reactive semiquinone species. We propose that possession of 469 
these enzymes by C. jejuni is important during its in vivo and ex vivo life-cycle and could be 470 





























































Bacterial cultures and strains 474 
Bacteria were stored using Protect bacterial preservers (Technical Service Consultants, 475 
Heywood, U.K.) at − 80 °C. C. jejuni strains, were streaked on blood agar (BA) plates 476 
containing Columbia agar base (Oxoid) supplemented with 7% (v/v) horse blood (TCS 477 
Microbiology, UK) and Campylobacter Selective Supplement (Oxoid), and grown at 37 °C in 478 
a microaerobic chamber (Don Whitley Scientific, UK), containing 85% N2, 10% CO2, and 479 
5% O2 for 48 hrs. C. jejuni strains were grown on Columbia blood agar (CBA) plates for a 480 
further 16 hrs prior to use. Strain 11168H of Multilocus Sequence Type (MLST) clonal 481 
complex ST-21, a hypermotile derivative of the original strain NCTC11168 that shows a 482 
higher level of caeca colonization in a chick model (8) was used in this study. Construction of 483 
mutants in which rrpA and rrpB have been inactivated to give isogenic mutants ΔrrpA and 484 
ΔrrpB has been previously described (6, 7).  485 
 486 
Protein expression and purification 487 
Recombinant RrpA, RrpB and their variants RrpACys8Ser, RrpACys13Ser, RrpACys33Ser, 488 
RrpACys113Ser, RrpBCys8Ser and MdaB and NfrA were cloned into pET21a
+
 plasmid using 489 
NEBuilder® HiFi DNA Assembly Cloning Kit (New England Biolabs). The proteins were 490 
overexpressed in E. coli strain BL21(DE3). The cells were grown in LB broth containing 491 
0.6% Glycerol, 0.05% glucose and 0.2% lactose and 100 μg/mL Ampicillin at 37 °C 492 
overnight. Cells were harvested by centrifugation at 4,000 × g for 15 mins at 4°C and 493 
resuspended in buffer A (20 mM Tris-HCl, pH 8.0 500 mM NaCl, 5% (vol/vol) glycerol, 5 494 
mM 2-Mercaptoethanol containing EDTA-free Complete Protease Inhibitor Mixture (Roche)) 495 



























































supernatant was incubated with Ni-NTA agarose nickel-charged resins (Qiagen) that had 497 
been equilibrated in buffer A. The protein bound resin was washed with buffer A containing 498 
15 mM imidazole and eluted with buffer A containing 400 mM imidazole. Primers used to 499 
generate recombinant proteins are presented in Supplementary file 4 (Table. S4a). 500 
 501 
Gene expression by RNA-Seq and bioinformatics analysis 502 
RNA-Seq was used to identify differentially expressed genes between wild type strains, 503 
∆rrpA and ∆rrpB mutants at mid-log (~6 hrs) of growth. C. jejuni 11168H wild type, 504 
11168H∆rrpA, 11168H∆rrpB and 11168H∆rrpAB were plated out on BA plates and 505 
incubated at 37 °C under microaerobic conditions for 6 hrs, 25 ml of pre-incubated brucella 506 
was inoculated with C. jejuni strains at an OD600nm 0.1 and grown at 37 °C under 507 
microaerobic conditions as described above. Transcription was stopped by RNA protect 508 
(Qiagen), RNA was extracted by PureLink™ RNA Mini Kit (Invitrogen), following 509 
manufactures protocol. Ribosomal RNA was depleted using Ribominus (Invitrogen) and 510 
libraries was prepared using TruSeq® Stranded mRNA (Illumina). Raw reads were obtained 511 
from an Illumina MiSeq paired-end sequencing platform (Illumina). The paired-end reads 512 
were trimmed and filtered using Sickle v1.200 (64), Bowtie2 (65) was used to map the reads 513 
against the reference sequence; C. jejuni strains 11168H assembly GCA_900117385.1. 514 
Cufflinks suite (66) was used to convert annotations from GFF to GTF format and Bedtools  515 
(67) was used to generate transcript counts per samples. Statistical analysis was performed in 516 
R using the combined data generated from the bioinformatics as well as meta data associated 517 
with the study (multifactorial design). Adjusted p-value significance cut-off of 0.05 and log 518 
fold change cut-off of >1.5 was used for multiple comparison. 519 
 520 



























































Expression of genes of interest were quantified by real-time RT-qPCR and normalized 522 
against gyrA. A 1 μg volume of total RNA of each sample was reverse-transcribed to cDNA 523 
using RT
2
 first strand kit (Qiagen) according to manufactures protocol. Quantification of 524 
gene expression was achieved by real-time RT-qPCR using TaqMan primers and probes 525 
created by the Assay-by-Design Service of Applied Biosystems (Table. S4b). Real-time RT-526 
PCR was performed in 96-well plates using an ABI PRISM 7300 Real-time PCR System 527 
(Applied Biosystems) and the relative gene expression for the different genes was calculated 528 
from the crossing threshold (Ct) value according to the manufacturer's protocol (
2−
ΔΔCt) after 529 
normalization using the gyrA endogenous control (68). 530 
 531 
DNAse I footprinting and electrophoretic mobility shift assay   532 
DNAse I footprinting was performed as previously described (29). Briefly, a 393 bp DNA 533 
fragment was PCR amplified with primers modified with Fluorescein amidite (FAM) and 534 
Hexachloro-fluorescein (HEX). Primers were used to amplify regions upstream of the 535 
translation initiation sites of rrpA and mdaB (cj1546Ffam and cj1546Rhex), and for rrpB and 536 
nfrA (cj1556Ffam and cj15556Rhex). PCR was performed for 30 cycles at the following 537 
conditions: 95 °C for 60 sec, 58 °C for 60 sec, 72 °C for 60 sec. The FAM/HEX‐labelled 538 
probes were cleaned using QiAquick PCR purification kit (Qiagen) and quantified with 539 
Nanodrop
TM
 spectrometer (Thermo Scientific). For the DNase I footprinting assay, 500 ng 540 
probes were incubated with varying concentration (from 20 μg to 0 μg) of RrpAhis6 or 541 
RrpBhis6 in a total volume of 40 μl in buffer containing (30 mM potassium glutamate, 1 mM 542 
dithiothreitol (DTT), 5 mM magnesium acetate, 2 mM CaCl2, 0.125 mg/mL bovine serum 543 
albumin (BSA), 30% glycerol in 10 mM Tris HCl, pH 8.5). After incubation for 20 min at 25 544 
°C, 10 μl of 0.02 unit of DNase I (NEB) was added to the binding reaction and incubated for 545 



























































for 10 mins. Samples were cleaned and eluted in 20 μl of dH2O. The samples were run with 547 
the 3730 DNA Analyzer and viewed with Gene mapper v6 (Applied Biosystems). 548 
 549 
For EMSA, purified RrpAhis6 (0.05 µg) was incubated with IRDye® 800 DNA fragments 550 
spanning the identified binding regions upstream of the translation start sites of mdaB 551 
(mdaBprobe) and rrpA (rrpAprobe) and RrpBhis6 (0.05 µg) with nfrA(nfrAprobe) and rrpB 552 
(rrpBprobe), a 50 nm probe was used in a 20 µl reaction. Odyssey® Infrared EMSA kit (LI-553 
COR Biosciences) was used according to the manufacture instructions. Samples were loaded 554 
in a pre-cast 6% Novex® DNA retardation gel (Life Technologies) and run at 4 °C and gels 555 
were analyzed on a LI-COR Odyssey® imaging scanner (LI-COR Biosciences). List of 556 
primers for DNAse I footprinting and probes for EMSA are found in Table. S4c. 557 
 558 
In vitro post translation modification analysis using LC-MS/MS  559 
Recombinant (1 µg) RrpAhis6 was treated with 50 µM 2-hydroxy-1,4-napthoquinone or 50 560 
µM H2O2 and RrpBhis6 was treated with 100 µM H2O2 for 30 mins at room temperature. 561 
Samples were resuspended in 500 µl of 50 mM tetraethylammonium bicarbonate (TEAB; 562 
Sigma), vortexed, and centrifuged at 14,000 rpm for 1 min. Overnight trypsin digestion at 37 563 
o
C was performed without the reduction and alkylation of cysteine residues to protect post-564 
translational modification. Samples were dried and resuspended in 40 µl of 2% acetonitrile in 565 
0.05% formic acid, 10 µl of which was injected to be analyzed by LC-MS/MS. 566 
Chromatographic separation was performed using a U3000 UHPLC NanoLC system 567 
(Thermo Fisher Scientific). Peptides were resolved by reversed phase chromatography on a 568 
75 µm C18 Pepmap column (50 cm length) using a four-step linear gradient of 80% 569 
acetonitrile in 0.1% formic acid. Raw mass spectrometry data was processed into peak list 570 



























































processed and searched using the Sequest search algorithm (69) against a bespoke database 572 
containing the RrpA and RrpB protein sequences obtained from Uniprot (Q0P879 (RrpA) and 573 
Q0P870 (RrpB)). 574 
 575 
Reductase assays 576 
An assay mixture consisting of 50 mM Tris-HCl, 100 mM NaCl, 10 % v/v DMSO, 200 µM 577 
NADPH and 2 µM MdaB was sparged with oxygen-free nitrogen for 7 mins, followed by 578 
incubation at 37 
o
C for 2 mins. Absorbance was recorded at 360 nm for 30 secs before the 579 
addition of 0.2 mM substrate. NADPH consumption was recorded for a further 1.5 mins. 580 
FMN and FAD were prepared in dH2O, while riboflavin was prepared in 10 mM NaOH, 581 
NfrA activity was determined at an absorbance of 340 nm and NAD(P)H consumption was 582 
recorded for a further 3 mins. No protein controls were performed with all substrates. 583 
 584 
Growth measurement 585 
Brucella broth was pre-incubated at 37 °C under microaerobic conditions for 24 hrs. 586 
Following overnight growth on BA, the bacteria cells were sub-cultured in 10 ml of the pre-587 
incubated broth in a 30 ml flask at an OD600nm = 0.01 at 37 °C under microaerobic conditions 588 
and grown to OD600nm = 0.4. Compounds were added to the respective strains at a 589 
concentration indicated and OD600nm readings were performed at selected time points.  590 
 591 
Statistics 592 
Statistical analysis for RNA-Seq were performed in R using the combined data generated 593 
from the bioinformatics as well as meta data associated with the study (multifactorial design). 594 
Differentially expressed genes were considered significant when the p-value of five 595 



























































ANOVA with Šídák multiple comparison test and student t-tests were performed to obtain p-597 
values using the software GraphPad Prism (Version 9, GraphPad Software, Inc.). 598 
 599 
Data availability: The data that support the RNA-seq findings of this study are openly 600 
available in Gene Expression Omnibus (GEO) at https://www.ncbi.nlm.nih.gov/geo/,  dataset 601 
identifier: GSE174333. Data that supports the post translational modification finding of this 602 
study are openly available in ProteomeXchange via the PRIDE database at  603 
http://doi.org/10.6019/PXD025924, dataset identifier: PXD025924. 604 
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Figure Legends: 813 
Figure. 1. Relative gene expression of a) mdaB; b) nfrA; c) capA; and d) rsmA. 814 
Expression of the genes were determined by real-time RT-PCR and are displayed relative to 815 
the wild type expression, after normalization with gyrA. Data presented is the mean value of 816 
at least 3 independent experiments performed on different days, error bars indicate S.D. *p < 817 
0.05; paired Student t-test was used; **p < 0.01, ***p < 0.001. 818 
 819 
Figure. 2. Electropherograms of fluorescent dye-labelled DNA fragments. Reduced 820 
electropherograms signals indicate protection regions by RrpAhis6 upstream of a) mdaB and 821 
b) rrpA. Protection regions by RrpBhis6 upstream of c) rrpB. (Region within the lines indicate 822 
protected regions, blue and green electropherograms indicate FAM and Hex fluorescently 823 
labelled DNA fragments, respectively. The electropherograms are presented as arbitrary 824 
scale). Panels d and e) show the protected regions by RrpAhis6 (grey highlight) including the 825 
inverted repeat sequence (bold and underlined), upstream of rrpA and mdaB transcription 826 
start sites, panel f) shows the protected region by RrpBhis6 (grey highlight) upstream rrpB 827 
(inverted repeat sequences are bold and underlined) and panel g) sequence alignment of rrpB 828 
protected region and the region upstream nfrA are matched (red asterisks). Nucleotides 829 
highlighted in green indicate C. jejuni ribosomal biding site (70) and yellow highlight 830 
indicates gene translation start site. Electropherograms are representative of three 831 
experiments. 832 
 833 
Figure. 3. Electrophoretic Mobility Shift Assay. EMSA was conducted to confirm RrpAhis6 834 
and RrpBhis6 DNA binding activity; RrpAhis6 (0.05 µg) binds upstream a) mdaB and RrpBhis6 835 
(0.05 µg) binds upstream b) nfrA. RrpAhis6 binds upstream c) rrpA; and RrpBhis6  binds 836 
upstream d) rrpB; Binding is indicated by shift of band (red arrows). IRDye® 800 DNA 837 




























































Figure 4. mdaB and nfrA respond to structurally diverse quinones and flavins. 840 
Expression levels of a) mdaB and rrpA; b) mdaB in ∆rrpA mutant strain at 15 mins after 841 
treatment with 100 µM of quinones; and c) nfrA and rrpB at 15 mins after treatment with 100 842 
µM of flavins. Growth in brucella broth was determined by measuring OD600nm every 15 843 
mins after addition of d) 100 µM 2-hydroxy-1,4-naphthoquinone to 11168H, ΔrrpA and 844 
ΔmdaB strains and e) 500 µM riboflavin to 11168H, ΔrrpB and ΔnfrA strains at OD600nm = 845 
~0.45. Cell viability was determined at 60 mins and 120 mins after treatment with f) 100 µM 846 
of 2-hydroxy-1,4-naphthoquinone and g) 500 µM of Riboflavin. Gene expression was 847 
determined by real-time RT-qPCR after treatment with compounds and is displayed relative 848 
to the value of the control expression, after normalization with gyrA expression. The values 849 
are the means of at least three independent experiments. Error bars = SD., *p ≤ 0.05, 850 
**p ≤ 0.01, ***p ≤ 0.001. 851 
 852 
Figure 5. Reductase activity of purified recombinant MdaB and NfrA. a) UV–visible 853 
spectrum of MdaB showing characteristic flavin cofactor absorbance peaks, inset shows the 854 
magnified view of the absorption spectra; b) Traces of quinone reductase assay with purified 855 
MdaBhis6 and NADPH (average of triplicates); c) Specific activity of MdaBhis6 with quinone 856 
substrates calculated from initial rate (arrow indicate <0); d) Riboflavin reductase activity of 857 
purified NrfAhis6 showing preference for NADPH over NADH; e) Specific activity of 858 
NrfAhis6 with flavin substrates and NADPH; f) Direct measurement of riboflavin reduction by 859 
NrfAhis6 and NADPH anaerobically by following the riboflavin absorbance maximum of 445 860 




























































Figure 6. The effect of redox cycling compounds on protein-DNA complex. EMSA was 863 
used to test the effect of 10 µM 2-hydroxy-1,4-naphthoquinone and 50 µM H2O2 on 0.05 µg 864 
of RrpAhis6 binding to its DNA substrates a) mdaB and b) rrpA; and the effect of H2O2 on 865 
0.05 µg of RrpBhis6 binding to its substrates c) nfrA and d) rrpB. Binding is indicated by shift 866 
of band (red arrows). IRDye® 800 DNA fragments were used.  867 
 868 
Figure 7. Identification of conserved cysteine residues in RrpA and RrpB proteins. a) 869 
Sequence alignment of RrpA and RrpB with other MarR family transcriptional regulators; b) 870 
RrpAhis6, RrpBhis6 and their variants were subjected to non-reducing SDS-PAGE analysis; 871 
c) RrpA and RrpB variants with mutation to cysteine residues were generated and EMSAs 872 
were conducted to determine their role DNA substrate binding; e) RrpAcys8Ser, RrrpAcys13Ser, 873 
RrpAcys33Ser, RrpAcys113Ser and f) RrpBcys8Ser. Approximately 0.05 ng of RrpA and 0.05 ng of 874 
RrpB variants in the presence of 50 nM DNA substrate was used (the red arrows indicate 875 
protein-DNA substrate complexes). Clustal Omega was used for multiple sequence 876 
alignment, yellow highlight with red asterisk indicate conserved Cys across all MarR family 877 
transcription regulators, grey highlight indicates non-conserved Cys in RrpA. 878 
 879 
Figure 8. Model for the activation of expression and function of MdaB and NfrA by 880 
RrpA and RrpB.  Structurally diverse quinones (Q) and flavins (F) produced by other 881 
bacteria in the intestinal microbiota or other environments encountered by C. jejuni enter the 882 
cell where they easily abstract single electrons from the flavins or metal centers of cellular 883 
redox enzymes (62) to form partially reduced semiquinones (SQ) or flavo-semiquinones 884 
(FSQ). In the presence of molecular oxygen, these can lead to the formation of toxic 885 
superoxide and other ROS (hydrogen peroxide), which may be dealt with by superoxide 886 



























































oxidation of Cys13 of RrpA and Cys8 of RrpB, although the exact species which effects this 888 
oxidation is not known. It is also possible that Q/F- Cys adduct formation (by Michael 889 
addition) may occur (dashed line).  Oxidized/modified RrpA C13 to C13-SO2H leads to an 890 
increased activation of the divergently transcribed gene mdaB, leading to production of 891 
MdaB, which is a quinone reductase that can fully reduce quinones to quinols (HQ) by two-892 
electron transfer from NADPH. RrpB is a negative regulator of the divergently transcribed 893 
nfrA gene, encoding an NADPH dependent flavin reductase (NfrA).  We presume that 894 
oxidation/modification of RrpB C8-SH produces a C8-SO2-SH and C8-Dha (dehydroalanine) 895 
which destabilizes the dimer and in turn leads to the de-repression of nfrA expression, 896 
allowing NfrA to catalyze the formation of fully reduced flavin hydroquinone (FHQ). The 897 
two-electron transfer catalyzed by both MdaB and NfrA avoids the semiquinone-mediated 898 
production of ROS. It is not known if or how cycling back to the oxidized forms occurs. This 899 
mechanism leads to a decrease in the toxic threat from exogenous quinones and flavins, but it 900 



























































Table 1. Significantly differentially expressed genes at mid-log growth phase in the mutant strains ∆rrpA, ∆rrpB and ∆rrpAB 902 
* Individual statistical test indicated gene was upregulated (p<0.05). 903 
For the complete dataset for 11168H and ΔrrpA, ΔrrpB and ΔrrpAB mutants see Table. S1a, Table. S1b and Table. S1c. 904 
Strain Gene name Product Function Log
2
 Fold 
11168H ∆rrpA     
 cj1677 (capA) CapA – Campylobacter adhesion protein Adhesion protein 2.17 
 cj1545c (mdaB) MdaB -NAD(P)H-quinone reductase Putative reductase -1.98* 
     
11168H ∆rrpB     
 cj1556 (rrpB) RrpB - MarR-like transcriptional regulator Putative transcriptional regulator 3.85 
 cj1555c (nfrA) NfrA - Putative NAD(P)-dependent reductase Putative reductase 2.81 
 cj1677 (capA) CapA Campylobacter adhesion protein A 1.88 
     
11168H ∆rrpAB     
 cj1556 (rrpB) RrpB  Putative transcriptional regulator 3.17 
 cj1555c (nfrA) NfrA - Putative NAD(P)-dependent reductase Putative reductase 2.50 
 cj1719c (leuA) LeuA - 2-isopropylmalate synthase  Amino acid biosynthesis 1.98 
 cj1546 (rrpA) RrpA - MarR-like transcriptional regulator  Putative transcriptional regulator  1.77 
     
 cj1454c (rimO) RimO - methylthiotransferase Ribosomal protein 
methylthiotransferase 
1.69 
 cj1710c (rnJ) 
 
Rnj - Ribonuclease J 
 
An RNase that has 5'-3' 
exonuclease and possibly 
endonuclease activity 
1.69 
 cj1711c (ksgA)  KsgA/RsmA - methyltransferase Ribosomal RNA small subunit 
methyltransferase A 
1.60 
 cj0724 Putative Molybdenum cofactor biosynthesis protein Uncharacterized -2.01 
 cj0265c (torB) Cytochrome C-type heme-binding periplasmic 
protein   
Putative cytochrome C-type heme-




























































Table 2. PTM identification following database searching and manual verification of the matched fragmentation spectra for RrpAhis6 and 905 




Complete data set is presented in Table. S2.910 
Sample Peptide m/z Charge Mass Residue TIC 
intensity 
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Cys33 
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 990.48 2 1979 Cys8 37140 
RrpB (H2O2)       
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